Detalhe da pesquisa
1.
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives.
Ann Oncol
; 31(1): 30-40, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912793
2.
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
Ann Oncol
; 30(9): 1417-1427, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268127
3.
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.
Ann Oncol
; 29(1): 112-118, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950295
4.
Sentinel node biopsy in thin melanoma: a retrospective descriptive cohort study.
J Eur Acad Dermatol Venereol
; 36(10): e795-e796, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35622455
5.
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.
Ann Oncol
; 27(6): 1055-1061, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002107
6.
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer.
Br J Cancer
; 112(12): 1874-81, 2015 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25989270
7.
New pieces of the melanoma puzzle uncovered.
Ann Oncol
; 31(11): 1430-1431, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949715
8.
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.
Ann Oncol
; 26(8): 1710-4, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25851630
9.
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.
Ann Oncol
; 25(9): 1756-1761, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24942275
10.
Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC?
Br J Dermatol
; 179(6): 1422-1423, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30187449
11.
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials.
Cancer Med
; 12(8): 9392-9400, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880426
12.
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer.
ESMO Open
; 8(3): 101198, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119788
13.
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells.
Br J Cancer
; 106(10): 1648-59, 2012 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22569000
14.
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM).
ESMO Open
; 7(5): 100567, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994791
15.
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors.
Br J Cancer
; 105(3): 382-92, 2011 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21750552
16.
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer.
Br J Cancer
; 104(3): 427-32, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21245865
17.
How we treat locoregional melanoma.
ESMO Open
; 6(3): 100136, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930656
18.
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.
Cancer Treat Rev
; 96: 102177, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33798955
19.
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors.
Eur Rev Med Pharmacol Sci
; 24(7): 3829-3838, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329859
20.
Resistance mechanisms of tumour cells to EGFR inhibitors.
Clin Transl Oncol
; 11(5): 270-5, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19451059